Literature DB >> 31742000

Xanthelasma Palpebrarum: More than Meets the Eye.

Shailesh Khode1, Soon Heng Terry Tan1, En-Pei Amanda Tan1, Sandeep Uppal1.   

Abstract

Xanthelasma palpebrarum (XP) is the most common form of cutaneous xanthomata, and is important aesthetically, because of its close relation to the eyes, as well as medically for its association with cardiovascular disease (CVD). To provide avant-garde review discussing the various aspects of XP, including its aetio-pathogenesis and various treatment modalities. A structured Pubmed and Medline were searched for relevant articles. The finding of recent research has strongly espoused the link between XP and CVD, and mechanisms have been suggested for its formation. The new technologies have led to a multitude of treatment options for XP. XP is a multi-faceted entity; other than simple treatment of the cosmetic aspect of the disease, one must be cognizant of its cardiovascular implications. © Association of Otolaryngologists of India 2018.

Entities:  

Keywords:  Blepharoplasty; Cardiovascular disease; Laser; Lipid; Tri-chloroacetic acid; Xanthelasma palpebrarum

Year:  2018        PMID: 31742000      PMCID: PMC6848656          DOI: 10.1007/s12070-018-1345-0

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  65 in total

1.  Use of Erbium:YAG laser in the treatment of palpebral xanthelasmas.

Authors:  G Mannino; A Papale; F De Bella; R Mollo; P Morgia; C B Gabrieli
Journal:  Ophthalmic Surg Lasers       Date:  2001 Mar-Apr

2.  Xanthelasma palpebrarum following allergic contact dermatitis from para-phenylenediamine in a black eyelash-tinting product.

Authors:  J Bhat; A G Smith
Journal:  Contact Dermatitis       Date:  2003-12       Impact factor: 6.600

3.  Effectiveness of low-voltage radiofrequency in the treatment of xanthelasma palpebrarum: a pilot study of 15 cases.

Authors:  Didem Dincer; Erol Koc; A Hakan Erbil; Osman Kose
Journal:  Dermatol Surg       Date:  2010-10-11       Impact factor: 3.398

4.  Low-density lipoprotein accumulation in actively growing xanthomas.

Authors:  P J Scott; C C Winterbourn
Journal:  J Atheroscler Res       Date:  1967 Mar-Apr

5.  Disappearance of eyelid xanthelasma following oral simvastatin (Zocor).

Authors:  C L Shields; A Mashayekhi; J A Shields; P Racciato
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

6.  Bilateral circular xanthelasma palpebrarum.

Authors:  Jungmin Kim; Yu Jin Kim; Hyoseob Lim; Se Il Lee
Journal:  Arch Plast Surg       Date:  2012-07-13

7.  Hyaluronan forms complexes with low density lipoprotein while also inducing foam cell infiltration in the dermis.

Authors:  Masahiro Seike; Mitsunori Ikeda; Masaaki Matsumoto; Rie Hamada; Motohiro Takeya; Hajime Kodama
Journal:  J Dermatol Sci       Date:  2005-12-13       Impact factor: 4.563

8.  Xanthelasma palpebrarum associated with increased cardio-ankle vascular index in asymptomatic subjects.

Authors:  Ali Rıza Akyüz; Turhan Turan; Musluhittin Emre Erkuş; İsmail Gürbak; Selim Kul; Levent Korkmaz; Mustafa Tarık Ağaç; Şükrü Çelik
Journal:  Wien Klin Wochenschr       Date:  2016-03-14       Impact factor: 1.704

9.  Evaluation of three different strengths of trichloroacetic acid in xanthelasma palpebrarum.

Authors:  Moin-Ul Haque; V Ramesh
Journal:  J Dermatolog Treat       Date:  2006       Impact factor: 3.359

10.  Xanthelasma palpebrarum: a new side effect of nilotinib.

Authors:  Irmak Sayin; Meltem Ayli; Ali Kemal Oğuz; Güldane Cengiz Seval
Journal:  BMJ Case Rep       Date:  2016-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.